Download presentation
Presentation is loading. Please wait.
Published byReginald Flynn Modified over 9 years ago
1
ADHD and Psychopharmacology By Monica Robles M.D
2
ADHD: prevalence and treatment Recent studies suggests that ADHD is under diagnosed in the US 1300 children were interviewed in 4 US communities 5% met criteria for ADHD Only 14% of them had been treated with medication in the past 12 months
3
Pharmacotherapy ADHD It is the cornerstone of treatment Decision to treat should be based on severity of symptoms
4
Impairment related to ADHD Psychiatric comorbidity School failure Peer relationship dysfunction Legal difficulties Smoking and substance abuse Accidents and injuries Family conflict Parent stress
5
MTA study 579 kids ages 7-9 with ADHD were studied for 14 months 1.Medication management by child psychiatrist 2.Behavioral therapy 3.Combination of medication and therapy 4.Community visits with the pediatrician
6
Results MTA study All the treatment groups were effective BUT MEDICATION MANAGEMENT ALONE BETTER THAN COMBINATION
7
Summary of the study Well delivered medication may be enough for the treatment of ADHD Behavioral management is also an acceptable method for those who prefer not to use medication
8
ATTENTION: ask for therapy Parent-child conflict or family stress Serious academic difficulties Social skills Anxiety symptoms or depression Oppositional or aggressive symptoms If the family wants it.
9
ADHD pharmacotherapy ADHD has largest body of data of any medication treatment for childhood psychiatric disorder
10
What do stimulants do Improve core symptoms of ADHD inattention Impulsivity hyperactivity
11
What do stimulants do noncompliance Impulsive aggression Social interaction Academic efficiency Academic accuracy Enhanced vigilance Improve reaction time Improve short term memory
12
Stimulants: mechanism of action They work inside of our brain controlling release of neurotransmitters and inhibiting reuptake
13
Stimulants Methylphenidate Amphetamine preparations
14
Stimulants Short-acting Focalin, Methylin, Ritalin Intermediate-acting Metadate ER and CD, Methylin ER,Ritalin LA and SR Long-acting Concerta, Focalin XR and Daytrana
15
Stimulants: amphetamine Short-acting Adderall, Dexedrine, Dextrostat Long-acting Adderall XR, Dexedrine Spansule, Vyvanse
16
Stimulants(adverse effects) Use caution in hx of drug dependency and alcoholism Serious cardiac history history of psychotic symptoms or bipolar disorder
17
Stimulants side effects Decrease appetite Gastrointestinal problems
18
Stimulants side effects Headache
19
Stimulants side effects Sleep difficulties
20
Stimulants side effects Jitteriness Irritability Anxiety Depression
21
Stimulants side effects Psychosis and paranoia
22
Stimulants side effects Tics or abnormal movements
23
Stimulants side effects Nail biting Skin picking
24
Stimulants side effects Rebound
25
Stimulants side effects Cardiac side effects 1.Increases blood pressure 2.Cardiac complications
26
Areas of concern and controversy When to do EKG Family history of sudden death Personal history of congenital cardiac defects syncope,CP, palpitation or increase BP
27
Stimulants side effects Growth Effects Adult height appears to be uncompromised
28
Abuse potential of stimulants No scientific data that ADHD children abuse meds when appropriately administered.
29
Alternatives to stimulants Around 15% nonresponders Intolerable side effects Symptom rebound Complicated ADHD with comorbidity.
30
Alternatives to stimulants Atomoxetine(Strattera) Tricyclic antidepressants Clonidine and guanfacine Bupropion Others
31
Atomoxetine Approved by FDA 2002 Non stimulant med approved for kids and adults Selective NE reuptake inhibitor Minimum abuse potential
32
Atomoxetine side effects Appetite suppression Sleep disturbance Jitteriness and irritability NAUSEA Small increase of pulse and Blood pressure
33
Black Box warning Hepatitis( 2 cases) Notify doctor if: dark urine, abdominal pain, yellow skin or eyes. Suicidality
34
Atomoxetine benefits It lasts all day Little or no rebound No abuse potential
35
Non-pharmacological treatment Education and Support: parent centered advocacy groups such as CHADD Decrease stimulation and increase structure School intervention Parent therapy/guidance (behavioral) Social skills therapy
36
School intervention Evaluate for comorbid learning disabilities Provide special education support Classroom accommodations Resource room if needed( smaller classroom) Aides in the class Individual tutoring
37
Psychosocial therapy Child’s ADHD symptoms are mild with minimal impairment Uncertainty of ADHD diagnosis Marked disagreement about ADHD diagnosis Preference of the family Presence of comorbid disorders or problems that usually respond to therapy Family problems need to be address
38
Summary :ADHD treatment We need to recognize ADHD as a chronic disorder Define the target behaviors Create an alliance that will include patient/parents/teacher and clinician Provide patient and parents education about ADHD Make a rational decision about the use of medication Include psychosocial therapy when needed SYSTEMATIC MONITORING, REVIEW and FOLLOW UP
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.